Stocktoria
Rafael Holdings, Inc. RFL
NYSE · stock · Pharmaceutical Preparations · website · IPO 2018-03-12
Rafael Holdings, Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $917,000 | $637,000 | $279,000 | $410,000 | $802,000 | $4.9M | $4.9M | $4.4M | $5.6M |
| R&D expense | $12.8M | $4.2M | $6.3M | $8.7M | $4.9M | $2.4M | $1.0M | $995,000 | — |
| SG&A expense | — | — | — | $17.0M | $17.0M | $9.1M | $8.8M | $5.5M | $3.7M |
| Operating income | -$29.2M | -$102.6M | -$15.0M | -$60.5M | -$28.2M | -$8.5M | -$6.7M | -$3.8M | $221,000 |
| Interest expense | $658,000 | $248,000 | — | $6,000 | $12,000 | — | — | — | — |
| Income tax | -$2.6M | -$2.7M | -$255,000 | — | $18,000 | $29,000 | -$19,000 | $8.4M | $66,000 |
| Net income | -$30.5M | -$34.4M | -$1.9M | -$124.7M | -$23.1M | -$10.8M | -$4.7M | -$11.6M | $138,000 |
| EPS (diluted) | $-1.04 | $-1.45 | $-0.08 | $-6.31 | $-1.49 | — | — | $-0.93 | $0.01 |
| Operating cash flow | -$18.9M | -$7.8M | -$10.9M | -$26.1M | -$15.6M | -$4.7M | -$3.1M | -$1.8M | -$1.6M |
| Free cash flow | -$18.9M | -$7.9M | — | -$26.1M | -$15.8M | -$5.2M | -$3.5M | -$2.5M | -$3.4M |
| Cash & equivalents | $52.8M | $2.7M | $21.5M | $26.5M | $7.9M | $6.2M | $12.0M | $15.8M | $11.8M |
| Inventory | $281,000 | — | — | — | — | — | — | — | — |
| Total assets | $114.1M | $96.8M | $98.8M | $118.3M | $154.1M | $136.3M | $142.1M | $116.9M | $86.2M |
| Total liabilities | $15.7M | $10.6M | $2.2M | $21.1M | $17.4M | $5.8M | $17.4M | $1.4M | $24.1M |
| Shareholders' equity | $98.4M | $86.3M | $100.3M | $100.5M | $136.7M | $130.5M | $124.8M | $116.1M | $62.1M |
Growth · year-over-year · Revenue CAGR -20.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +44.0% | +128.3% | -32.0% | -48.9% | -83.7% | -0.4% | +12.8% | -22.2% | — |
| Net income growth | — | — | — | — | — | — | — | -8541.3% | — |
| EPS growth | — | — | — | — | — | — | — | -9400.0% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-07-31. Facts plus Stocktoria's own computed scores — not investment advice.